Dynamic FDG PET/CT: Optimization and Validation of Data Acquisition
NCT04660279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-02-22
Summary
Quantification of the metabolic rate of glucose from Dynamic Whole-Body PET examinations requires measurements of the time course of the radioactivity concentrations in arterial blood by blood sampling, and in the tissue of interest by dynamic PET. Invasive arterial blood sampling cannot be part of a standard examination, and therefore the blood samples need to be replaced by activity concentrations derived from the PET images, usually from small volumes in the descending aorta or left ventricle.
Newly developed scanner software (Siemens) allows automated CT-based identification of blood pool regions and extraction of an image-derived blood input function from the corresponding PET data.
However, this automated method needs validation, as it could be prone to systematic errors caused by limited spatial resolution, patient movement, and image reconstruction. We will use invasively measured arterial blood samples as a reference for validation of methods to extract non-invasive PET image-derived input functions and quantify any systematic errors that could propagate to the resulting parametric images.
Conditions
- Positron-Emission Tomography
Interventions
- DIAGNOSTIC_TEST
-
Dynamic Whole-Body parametric PET/CT
Dynamic whole-body PET/CT imaging protocol
Sponsors & Collaborators
-
Aarhus University Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
NCT05908669 ·Status: ENROLLING_BY_INVITATION
-
Role of Dopamine Transporter in Glucose Control
NCT03466697 ·Status: COMPLETED ·Phase: NA
-
Correlation of Pre- and Post-operative Cancer Imaging Techniques
NCT04776291 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
NCT00522639 ·Status: TERMINATED ·Phase: PHASE3
-
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NCT06232889 ·Status: RECRUITING ·Phase: NA
-
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
NCT07203495 ·Status: ACTIVE_NOT_RECRUITING
-
CUP Project PET/CT
NCT01469026 ·Status: UNKNOWN ·Phase: PHASE4
-
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
NCT04272658 ·Status: RECRUITING
-
Molecular Evaluation in Metastatic Breast Cancer
NCT03358589 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
NCT02717572 ·Status: COMPLETED ·Phase: PHASE1
-
Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy
NCT01269970 ·Status: COMPLETED
-
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans
NCT00222768 ·Status: COMPLETED
-
Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Repeatability Study of Fatty Acid Uptake Using PET/MR Imaging in Patients With T2DM and Non-diabetic Control Subjects
NCT05132335 ·Status: COMPLETED ·Phase: NA
-
FDHT PET and Bicalutamide in Metastatic Breast Cancer
NCT02697032 ·Status: COMPLETED ·Phase: PHASE2
-
Dual PET/CT Imaging in Lung Cancer
NCT01539928 ·Status: UNKNOWN
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
Gastric Emptying Validation Pilot Study (MRI Val)
NCT05765123 ·Status: COMPLETED
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
NCT05140902 ·Status: COMPLETED ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
NCT04762719 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
Multi-Tracer Pet Quantitation of Insulin Action
NCT00715221 ·Status: COMPLETED